» Articles » PMID: 26967053

Long-range and Short-range Tumor-stroma Networks Synergistically Contribute to Tumor-associated Epilepsy

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Mar 12
PMID 26967053
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Epileptic seizures are frequently caused by brain tumors. Traditional anti-epileptic treatments do not acquire satisfactory responses. Preoperative and postoperative seizures seriously influence the quality of life of patients. Thus, tumor-associated epilepsy (TAE) is an important subject of the current research. The delineation of the etiology of epileptogenesis in patients with primary brain tumor may help to find the novel and effective drug targets for treating this disease. In this review, we describe the current status of treatment of TAE. More importantly, we focus on the factors that are involved in the functional connectivity between tumors and stromal cells. We propose that there exist two modes, namely, long-range and short-range modes, which likely trigger neuronal hyperexcitation and subsequent epileptic seizures. The long-range mode is referred to as factors released by tumors including glutamate and GABA, binding to the corresponding receptor on the cellular membrane and causing neuronal hyperactivity, while the short-range mode is considered to involve direct intracellular communication between tumor cells and stromas. Gap junctions and tunneling nanotube network are involved in cellular interconnections. Future investigations focused on those two modes may find a potential novel therapeutic target for treating TAE.

Citing Articles

Epilepsy in Patients with Gliomas.

Ehara T, Ohka F, Motomura K, Saito R Neurol Med Chir (Tokyo). 2024; 64(7):253-260.

PMID: 38839295 PMC: 11304448. DOI: 10.2176/jns-nmc.2023-0299.


Ferroptosis in glioma treatment: Current situation, prospects and drug applications.

Zhou Y, Fang C, Xu H, Yuan L, Liu Y, Wang X Front Oncol. 2022; 12:989896.

PMID: 36249003 PMC: 9557197. DOI: 10.3389/fonc.2022.989896.


Glioma-related seizures in relation to histopathological subtypes: a report from the glioma international case-control study.

Berntsson S, Merrell R, Amirian E, Armstrong G, Lachance D, Smits A J Neurol. 2018; 265(6):1432-1442.

PMID: 29687214 PMC: 5990563. DOI: 10.1007/s00415-018-8857-0.


ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner.

Chen D, Fan Z, Rauh M, Buchfelder M, Eyupoglu I, Savaskan N Oncogene. 2017; 36(40):5593-5608.

PMID: 28553953 PMC: 5633655. DOI: 10.1038/onc.2017.146.

References
1.
Chang E, Potts M, Keles G, Lamborn K, Chang S, Barbaro N . Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg. 2008; 108(2):227-35. DOI: 10.3171/JNS/2008/108/2/0227. View

2.
Segal G . Re: Brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst. 2000; 92(1):77-8. DOI: 10.1093/jnci/92.1.77. View

3.
Delpire E . Cation-Chloride Cotransporters in Neuronal Communication. News Physiol Sci. 2001; 15:309-312. DOI: 10.1152/physiologyonline.2000.15.6.309. View

4.
Ye Z, Rothstein J, Sontheimer H . Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J Neurosci. 1999; 19(24):10767-77. PMC: 6784962. View

5.
Zhu L, Polley N, Mathews G, Delpire E . NKCC1 and KCC2 prevent hyperexcitability in the mouse hippocampus. Epilepsy Res. 2008; 79(2-3):201-12. PMC: 2394664. DOI: 10.1016/j.eplepsyres.2008.02.005. View